In an immunohistochemical screening performed onto 87 high-grade gliomas specimens, the expression of MLK4 strongly correlated with that of CD44 (MES GBM marker) and turned out to be almost mutually exclusive with that of OLIG2 (PN GBM marker). Here, CD44 is linked to glioblastoma.